Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide

por Chang, J, Varghese, D S, Gillam, M C, Peyton, M, Modi, B, Schiltz, R L, Girard, L, Martinez, E D
Publicado 2012

Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer

por Viale, G., Basik, M., Niikura, N., Tokunaga, E., Brucker, S., Penault-Llorca, F., Hayashi, N., Sohn, J., Teixeira de Sousa, R., Brufsky, A.M., O’Brien, C.S., Schmitt, F., Higgins, G., Varghese, D., James, G.D., Moh, A., Livingston, A., de Giorgio-Miller, V.
Publicado 2023